MIRA Pharmaceuticals, Inc. Common Stock
Follow $MIRA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $MIRA by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MIRA moving today?
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MIRA overview
Related filings and maps
Congress activity in MIRA
No receipt-qualified Congressional disclosure is present for MIRA in the cached public ledger.
MIRA contract awards, year to date.
Public federal awards linked to this ticker.
MIRA lobbying filings, year to date.
Registered lobbying filings matched to MIRA Pharmaceuticals, Inc. Common Stock.